Mood disorders account for a significant global disease burden, and pharmacological
innovation is needed as existing medications are suboptimal. A wide range of evidence …

Background This narrative review aims to discuss several common neurological and
psychiatric disorders that show comorbidity with migraine. Not only can we gain …

The American Psychiatric Association Publishing Textbook of Psychopharmacology is an
indispensable and comprehensive resource for clinicians and trainees who prescribe …

Anhedonia is a hallmark feature of depression and is highly prevalent among individuals
with mood disorders. The history and neurobiology of anhedonia has been most extensively …

Lithium is an effective mood stabilizer in bipolar disorder (BD). There is, however, high
variability in treatment response to lithium and only 20–30% of individuals with BD are …

Introduction Lithium treatment is considered the gold standard for the long-term
management of bipolar disorder and recurrent unipolar depression. It is also extremely …

Over the last six decades, lithium has been considered the gold standard treatment for the
long-term management of bipolar disorder due to its efficacy in preventing both manic and …

Bipolar disorder (BD) is characterized by disrupted circadian rhythms affecting sleep,
arousal, and mood. Lithium is among the most effective mood stabilizer treatments for BD …

Background Bipolar disorder (BD) is characterized by episodes of depression and mania
and disrupted circadian rhythms. Lithium is an effective therapy for BD, but only 30%–40% of …

Background and Objectives: There is no biomarker to predict lithium response. This study
used CellPrint™ enhanced flow cytometry to study 28 proteins representing a spectrum of …